|
Summit Therapeutics Inc. (SMMT) DCF Valoración
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Summit Therapeutics Inc. (SMMT) Bundle
¡Evalúe la perspectiva financiera de Summit Therapeutics Inc. (SMMT) como un experto! Esta calculadora DCF (SMMT) proporciona datos financieros preconsados, al tiempo que le permite la libertad de modificar suposiciones como el crecimiento de los ingresos, WACC, los márgenes y más para alinearse con sus predicciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .8 | 1.1 | 2.3 | .9 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 36.07 | 110.35 | -61.07 | -100 | -6.25 | -6.25 | -6.25 | -6.25 | -6.25 |
| EBITDA | -21.1 | -46.7 | -78.9 | -66.2 | 1.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -2657.39 | -4317.95 | -3467.99 | -7472.75 | 100 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | 1.8 | 2.5 | 3.1 | 3.2 | 114.2 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 220.24 | 232.91 | 135.71 | 356.95 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -22.9 | -49.2 | -82.0 | -69.4 | -112.9 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -2877.63 | -4550.85 | -3603.7 | -7829.7 | 100 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 62.9 | 83.6 | 90.3 | 438.7 | 234.4 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6.7 | 12.8 | 1.8 | .4 | 1.1 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 837.59 | 1184.53 | 80.93 | 49.55 | 100 | 86.1 | 86.1 | 86.1 | 86.1 | 86.1 |
| Inventories | .0 | -14.7 | 9.0 | 379.4 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.000246828483 | -1361.63 | 395.85 | 42809.33 | 100 | 40 | 40 | 40 | 40 | 40 |
| Accounts Payable | 3.3 | 7.7 | 5.5 | .4 | 3.4 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 415.98 | 713.95 | 241.79 | 50.41 | 100 | 90.08 | 90.08 | 90.08 | 90.08 | 90.08 |
| Capital Expenditure | -.3 | -.5 | -.4 | -.8 | -.2 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -41.98 | -48.95 | -16.92 | -88.6 | 100 | -39.29 | -39.29 | -39.29 | -39.29 | -39.29 |
| Tax Rate, % | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 | 0.1536 |
| EBITAT | -19.2 | -49.1 | -79.8 | -65.5 | -112.7 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -21.2 | -34.1 | -92.0 | -437.2 | 383.0 | -2.3 | .0 | .0 | .0 | .0 |
| WACC, % | 5.48 | 5.51 | 5.51 | 5.5 | 5.51 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | 44 | |||||||||
| Equity Value | -46 | |||||||||
| Diluted Shares Outstanding, MM | 620 | |||||||||
| Equity Value Per Share | -0.07 |
What You Will Get
- Real SMMT Financial Data: Pre-filled with Summit Therapeutics’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Summit Therapeutics’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Clinical Data: Access reliable pre-loaded historical performance metrics and future clinical projections.
- Customizable Assumptions: Modify highlighted cells for variables such as R&D expenses, market growth rates, and profit margins.
- Automated Financial Analysis: Instant updates to DCF, Net Present Value (NPV), and revenue forecasts.
- User-Friendly Dashboard: Intuitive charts and summaries to easily interpret your financial assessments.
- Designed for All Users: A straightforward, user-centric layout suitable for investors, analysts, and industry professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based SMMT DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and more.
- Instant Calculations: The model automatically recalculates Summit Therapeutics' intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for Summit Therapeutics Inc. (SMMT)?
- Designed for Experts: A sophisticated tool favored by analysts, investors, and healthcare consultants.
- Comprehensive Data: Summit Therapeutics' historical and projected financials preloaded for precise analysis.
- Scenario Analysis: Effortlessly test various forecasts and assumptions to gauge potential outcomes.
- Transparent Results: Automatically computes intrinsic value, NPV, and essential metrics for informed decision-making.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the calculation process.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing Summit Therapeutics Inc. (SMMT).
- Pharmaceutical Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Summit Therapeutics Inc. (SMMT).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to biotech firms.
- Biotech Enthusiasts: Gain insights into how companies like Summit Therapeutics Inc. (SMMT) are valued in the healthcare market.
What the Summit Therapeutics Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Summit Therapeutics Inc. (SMMT).
- Real-World Data: Summit Therapeutics’ historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Summit Therapeutics Inc. (SMMT).
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for informed decision-making.